1. 2,4-Bis(1,1-dimethylethyl)phenol from Cinnamomum loureirii Improves Cognitive Deficit, Cholinergic Dysfunction, and Oxidative Damage in TMT-Treated Mice.
- Author
-
Kim CR, Choi SJ, Kim JK, Park CK, Gim MC, Kim YJ, Park GG, and Shin DH
- Subjects
- Acetylcholinesterase metabolism, Animals, Brain drug effects, Brain metabolism, Cognition Disorders chemically induced, Cognition Disorders metabolism, Lipid Peroxidation drug effects, Male, Maze Learning drug effects, Memory Disorders chemically induced, Memory Disorders metabolism, Mice, Inbred ICR, Neuroprotective Agents pharmacology, Oxidative Stress drug effects, Phenols pharmacology, Trimethyltin Compounds, Cinnamomum, Cognition Disorders drug therapy, Memory Disorders drug therapy, Neuroprotective Agents therapeutic use, Phenols therapeutic use
- Abstract
We previously reported that the extract of Cinnamomum loureirii (C. loureirii) significantly inhibited acetylcholinesterase (AChE), and identified 2,4-bis(1,1-dimethylethyl)phenol (BP) from C. loureirii as a potential AChE inhibitor. The present study, therefore was undertaken to demonstrate the effects of BP from C. loureirii on learning and memory impairment in trimethyltin (TMT)-treated ICR mice. Y-maze and passive avoidance tests were used to test cognitive ability. Further, changes in biochemical parameters in the brain tissue were also assessed in response to TMT injection and BP intervention. BP pre-administration (20, 40 mg/kg/d) in mice significantly protected cognitive dysfunction induced by TMT (p<0.05). Moreover, BP reduced AChE activity and lipid peroxidation but increased acetylcholine levels in the brain. In conclusion, we suggested that BP protected against TMT-induced cognitive dysfunction, and might be a potential agent for alleviating symptoms of neurodegenerative disorders, such as Alzheimer's disease, via modulating cholinergic functions.
- Published
- 2017
- Full Text
- View/download PDF